Spineway S.A (ALSPW) | Financial Analysis & Statements
Spineway S.A. | Small-cap | Healthcare
Spineway S.A. | Small-cap | Healthcare
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
12.0M
Gross Profit
8.5M
70.73%
Operating Income
-885.0K
-7.41%
Net Income
-3.9M
-32.34%
EPS (Diluted)
€0.00
Balance Sheet Metrics
Total Assets
30.4M
Total Liabilities
6.2M
Shareholders Equity
24.2M
Debt to Equity
0.25
Cash Flow Metrics
Operating Cash Flow
-3.9M
Free Cash Flow
-3.3M
Revenue & Profitability Trend
Spineway S.A Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 12.0M | 10.5M | 7.4M | 4.3M | 3.4M |
| Cost of Goods Sold | 3.5M | 2.6M | 1.4M | 826.0K | 412.1K |
| Gross Profit | 8.5M | 7.9M | 6.0M | 3.5M | 3.0M |
| Operating Expenses | 2.3M | 4.6M | 3.4M | 3.3M | 3.5M |
| Operating Income | -885.0K | -4.3M | -3.2M | -1.4M | -1.8M |
| Pre-tax Income | -3.9M | -6.5M | -3.1M | -1.6M | -14.0M |
| Income Tax | - | - | 0 | 0 | -231.6K |
| Net Income | -3.9M | -6.5M | -3.1M | -1.6M | -13.6M |
| EPS (Diluted) | €0.00 | -€0.82 | €0.00 | -€0.20 | -€48,193.74 |
Income Statement Trend
Spineway S.A Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 13.9M | 10.2M | 12.1M | 18.6M | 8.3M |
| Non-Current Assets | 16.5M | 16.2M | 15.6M | 6.9M | 6.6M |
| Total Assets | 30.4M | 26.3M | 27.7M | 25.6M | 14.9M |
| Liabilities | |||||
| Current Liabilities | 4.2M | 4.9M | 2.5M | 2.1M | 1.7M |
| Non-Current Liabilities | 1.9M | 2.4M | 3.2M | 2.6M | 3.0M |
| Total Liabilities | 6.2M | 7.3M | 5.7M | 4.7M | 4.7M |
| Equity | |||||
| Total Shareholders Equity | 24.2M | 19.1M | 22.0M | 20.9M | 10.2M |
Balance Sheet Composition
Spineway S.A Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -3.9M | -6.5M | -3.1M | -1.6M | -685.0K |
| Operating Cash Flow | -3.9M | -6.9M | -3.1M | -2.5M | -685.0K |
| Investing Activities | |||||
| Capital Expenditures | - | -794.0K | - | - | 0 |
| Investing Cash Flow | - | -724.0K | -10.2M | -1.2M | -48.0K |
| Financing Activities | |||||
| Dividends Paid | - | - | - | - | - |
| Financing Cash Flow | - | 3.5M | 3.6M | 10.7M | 872.0K |
| Free Cash Flow | -3.3M | -7.3M | -1.6M | -1.8M | -1.3M |
Cash Flow Trend
Spineway S.A Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
0.02
Forward P/E
4.37
Price to Book
0.07
Price to Sales
0.30
PEG Ratio
4.37
Profitability Ratios
Profit Margin
-30.35%
Operating Margin
-1.88%
Return on Equity
-17.85%
Return on Assets
-1.95%
Financial Health
Current Ratio
2.37
Debt to Equity
7.50
Beta
0.82
Per Share Data
EPS (TTM)
€0.00
Book Value per Share
€1.93
Revenue per Share
€0.09
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| alspw | 3.9M | 0.02 | 0.07 | -17.85% | -30.35% | 7.50 |
| Amplitude Surgical | 295.0M | 307.50 | 3.12 | 1.15% | 1.00% | 126.32 |
| Crossject S.A | 80.5M | - | - | 478.68% | 0.00% | -7.88 |
| Visiomed Group SA | 53.2M | 57.80 | 2.10 | 3.68% | 6.58% | 32.03 |
| Bonyf N.V | 8.2M | - | 18.85 | -38.97% | 8.54% | 0.00 |
| I.Ceram S.A | 155.7K | 9.88 | 0.46 | -124.00% | -170.02% | 476.65 |
Financial data is updated regularly. All figures are in the company's reporting currency.